The SCID-hu mouse as a model for HIV-1 infection
- PMID: 8515816
- DOI: 10.1038/363732a0
The SCID-hu mouse as a model for HIV-1 infection
Abstract
During normal fetal ontogeny, one of the first organs to harbour CD4-positive cells is the thymus. This organ could therefore be one of the earliest targets infected by human immunodeficiency virus type 1 (HIV-1) in utero. HIV-1-infected cells and pathological abnormalities of the thymus have been seen in HIV-1-infected adults and children, and in some fetuses aborted from infected women. Studies of HIV-1 pathogenesis have been hampered by lack of a suitable animal model system. Here we use the SCID-hu mouse as a model to investigate the effect of virus infection on human tissue. The mouse is homozygous for the severe combined immunodeficiency (SCID) defect. The model is constructed by implanting human fetal liver and thymus under the mouse kidney capsule. A conjoint human organ develops, which allows normal maturation of human thymocytes. After direct inoculation of HIV-1 into these implants, we observed severe depletion of human CD4-bearing cells within a few weeks of infection. This correlated with increasing virus load in the implants. Thus the SCID-hu mouse may be a useful in vivo system for the study of HIV-1-induced pathology.
Similar articles
-
The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.J Immunol. 1995 Jun 15;154(12):6612-23. J Immunol. 1995. PMID: 7759895
-
Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.J Immunol. 1995 Jan 15;154(2):907-21. J Immunol. 1995. PMID: 7814892
-
Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.Virology. 1999 Oct 10;263(1):78-88. doi: 10.1006/viro.1999.9869. Virology. 1999. PMID: 10544084
-
SCID-hu mice: a model for studying disseminated HIV infection.Semin Immunol. 1996 Aug;8(4):223-31. doi: 10.1006/smim.1996.0028. Semin Immunol. 1996. PMID: 8883145 Review.
-
The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS.Semin Immunol. 1996 Aug;8(4):215-21. doi: 10.1006/smim.1996.0027. Semin Immunol. 1996. PMID: 8883144 Review.
Cited by
-
Engineering approaches for regeneration of T lymphopoiesis.Biomater Res. 2016 Jun 29;20:20. doi: 10.1186/s40824-016-0067-1. eCollection 2016. Biomater Res. 2016. PMID: 27358746 Free PMC article. Review.
-
Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo.J Virol. 1999 Nov;73(11):9089-97. doi: 10.1128/JVI.73.11.9089-9097.1999. J Virol. 1999. PMID: 10516015 Free PMC article.
-
Functional reconstitution of thymopoiesis after human immunodeficiency virus infection.J Virol. 2000 Mar;74(6):2943-8. doi: 10.1128/jvi.74.6.2943-2948.2000. J Virol. 2000. PMID: 10684316 Free PMC article.
-
Human immunodeficiency virus persistence and production in T-cell development.Clin Vaccine Immunol. 2006 Nov;13(11):1237-45. doi: 10.1128/CVI.00184-06. Epub 2006 Sep 20. Clin Vaccine Immunol. 2006. PMID: 16988009 Free PMC article.
-
In Vivo validation of a bioinformatics based tool to identify reduced replication capacity in HIV-1.Open Med Inform J. 2010;4:225-32. doi: 10.2174/1874431101004010225. Epub 2010 Dec 3. Open Med Inform J. 2010. PMID: 21603285 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
